TITLE Nº  POSTER BOARD
GENETIC AND SEROLOGICAL PROFILE AS MARKERS OF DISEASE SUSCEPTIBILITY IN SIBLINGS OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE P001
ROLE OF MICRORNA-223 IN THE ACTIVATION OF POLY(ADP-RIBOSE) POLYMERASE IN PEDIATRIC PATIENTS WITH CROHN’S DISEASE P002
EARLY NUTRITIONAL PROGRAMMING: EFFECT OF BREASTFEEDING ON CROHN’S DISEASE NATURAL HISTORY P003
SUBSET ANALYSIS OF PERIPHERAL BLOOD IMMUNE CELLS IN PAEDIATRIC IBD REVEALS MEDICATION AND DISEASE ACTIVITY DEPENDENT CHANGES P004
PRESENCE OF EOSINOPHIL CELLS IN THE LOWER GASTROINTESTINAL TRACT OF HEALTHY CHILDREN – A META-ANALYSIS P005
FAECAL MICROBIOTA DYSBIOSIS IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE WORSENS AFTER THERAPY. P006
PROGNOSTIC VALUE OF PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY IN PEDIATRIC INFLAMMATORY BOWEL DISEASES P007
2016: THE EPIDEMIC OF INFLAMMATORY BOWEL DISEASE. P008
FIVE-YEAR FOLLOW-UP OF THE PROSPECTIVE NATION-WIDE HUNGARIAN PEDIATRIC IBD REGISTRY (HUPIR) P009
DIAGNOSTIC DELAY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE IN SPAIN: THE SPIDER REGISTRY P010
DEVELOPMENT AND VALIDATION OF DIAGNOSTIC CRITERIA FOR IBD SUBTYPES INCLUDING IBD-UNCLASSIFIED IN CHILDREN P011
PRELIMINARY STUDY OF ATYPICAL ULCERATIVE COLITIS AND INFLAMMATORY BOWEL DISEASE UNCLASSIFIED IN KOREAN PEDIATRIC ONSET IBD P012
ACP353, A NOVEL SEROLOGIC MARKER FOR DIAGNOSIS OF CROH’N DISEASE, IN JAPANESE CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A PILOT STUDY P013
FECAL CALPROTECTIN AS A RELIABLE MARKER FOR DIFFERENTIATING INFLAMMATORY BOWEL DISEASE FROM FOOD ALLERGY AND FUNCTIONAL ABDOMINAL  PAIN IN CHILDREN P014
FECAL METALLOPROTEINASE-9 AND SERUM TISSUE INHIBITOR OF METALLOPROTEINASE-1 DISCRIMINATE CHILDREN WITH CROHN’S DISEASE P015
FUNGAL DYSBIOSIS IN MUCOSA AND STOOL:ACCURACY IN PREDICTING DIAGNOSIS OF CROHN DISEASE IN CHILDREN P016
SMALL BOWEL CAPSULE ENDOSCOPY EXAMINATIONS FOR DETECTING SMALL INTESTINAL LESIONS OF CROHN DISEASE IN CHILDREN – A 7 YEARS EXPERIENCE P017
WIRELESS CAPSULE ENDOSCOPY: EXPLORING THE BOWEL IN PEDIATRIC IBD PATIENTS P018
INFLAMMATORY BOWEL DISEASE – “RECLASSIFIED” P019
A SINGLE CENTRE STUDY COMPARING USS SMALL BOWEL AND MRI ENTEROCLYSIS IN EARLY ONSET CROHN’S DISEASE P020
IMAGENOLOGICAL CHARACTERIZATION OF INTESTINAL INFLAMMATORY DISEASE IN CHILDREN. P021
INFLAMMATORY BOWEL DISEASE IN CHILDREN IS A CHALLENGING DIAGNOSIS WHEN OVERLAPS WITH COELIAC DISEASE P022
LABORATORY VALUES IN JAPANESE CHILDREN WITH NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASE: A SINGLE-CENTER EXPERIENCE P023
VITAMIN D LEVELS IN CHILDREN LIVING IN ENGLAND P024
PAEDIATRIC IBD PATIENTS DO NOT MEET THE MINIMUM DAILY REQUIREMENTS OF VITAMIN D AND CALCIUM INTAKE: TERTIARY CENTRE SURVEY-BASED ANALYSIS P025
RISK FACTORS FOR VITAMIN D DEFICIENCY IN CHILDREN WITH CROHN’S DISEASE OR ULCERATIVE COLITIS: A RETROSPECTIVE COHORT STUDY IN CANADA. P026
BONE HEALTH ASSESSMENT IN PEDIATRIC INFLAMMATORY BOWEL DISEASE AT DIAGNOSIS P028
ABNORMAL BONE MINERAL DENSITY IN PATIENTS WITH PAEDIATRIC INFLAMMATORY BOWEL (PIBD) DISEASE IN A TERTIARY HOSPITAL P028
BONE MINERAL DENSITY AS MARKER OF NUTRITIONAL STATUS IN PEDIATRIC IBD P029
BODY COMPOSITION ANALYSIS USING BIOELECTRICAL IMPEDANCE IN PAEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE P030
PEDIATRIC INFLAMMATORY BOWEL DISEASE AND ATTAINED FINAL HEIGHT-A POPULATION BASED COHORT STUDY P031
PHENOTYPE, TREATMENT AND OUTCOME OF PATIENTS WITH VERY EARLY ONSET IBD AND INFANTILE IBD: RESULTS FROM THE CEDATA-GPGE REGISTRY P032
EVALUATION OF AUTONOMIC NERVOUS SYSTEM FUNCTIONS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE IN REMISSION P033
AN EXAMINATION OF THE CLINICAL OUTCOMES OF ULCERATIVE COLITIS PATIENTS WITH MUCOSAL ATROPHY IN THE IRISH CENTRE FOR PAEDIATRIC GASTROENTEROLOGY P034
AN EXAMINATION OF THE EFFECT OF DEEP ULCERATION ON CLINICAL OUTCOMES FOR PATIENTS WITH CROHN’S DISEASE. P035
ASSOCIATION BETWEEN CLINICAL AND PATHOLOGICAL FINDINGS IN PEDIATRIC ONSET IBD PATIENTS, A RETROSPECTIVE ANAYLSIS FROM A TERTIARY CENTER P036
DIAGNOSTIC GASTROSCOPY PREDICTS OUTCOME FOLLOWING RIGHT HEMICOLECTOMY IN PAEDIATRIC CROHN’S DISEASE P037
DIFFERENCES BETWEEN PAEDIATRIC AND ADULT IBD – ANALYSIS BASED ON THE DATA FROM MULTICENTER, PROSPECTIVE COHORT OBSERVATIONAL SATIMOS STUDY. P038
INFLAMMATORY BOWEL DISEASE IN CHILDREN WITH SPECIAL HEALTH CARE NEEDS P039
DISEASE PHENOTYPE OF KOREAN PEDIATRIC CROHN’S DISEASE PATIENTS AT DIAGNOSIS: A MULTICENTER RETROSPECTIVE COMPARATIVE STUDY WITH EUROKIDS P040
MALIGNANCY AND MORTALITY IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW P041
GLOBAL VARIATION IN USE OF EXCLUSIVE ENTERAL NUTRITION FOR PEDIATRIC CROHN DISEASE P042

 

 

DOES STANDARD THERAPY IN PAEDIATRIC CROHN´S DISEASE REALLY PREVENT OUR PATIENTS FROM THE NEED OF EARLY INITATION OF ANTI-TNF TREATMENT? P043
THE GUT VIROME OF PEDIATRIC CROHN’S DISEASE (CD) FOLLOWING EXCLUSIVE ENTERAL NUTRITION P044
COMBINATION OF ORAL ANTIBIOTIC AS A RESCUE THERAPY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: OUR EXPERIENCE P045
THIOPURINES TREATMENT IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A SURVIVAL ANALYSIS OF THE LONG TERM EFFICACY P046
RELIABILITY OF HEMATOLOGIC INDICES FOR MONITORING THIOPURINE THERAPY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE P047
EPSTEIN-BARR VIRUS STATUS AND THIOPURINE THERAPY IN PEDIATRIC IBD: A 20-YEAR SINGLE CENTRE EXPERIENCE P048
CYCLOSPORIN A EFFICACY IN PAEDIATRIC ULCERATIVE COLITIS- A  RETROSPECTIVE SINGLE  CENTER STUDY. P049
OUTCOMES OF ORAL TACROLIMUS INDUCTION AND MAINTENANCE THERAPY FOR CHILDREN WITH ULCERATIVE COLITIS: A SINGLE CENTER STUDY. P050
CAN EARLY NEED OF BIOLOGIC THERAPY IN PATIENTS TREATED WITH EXCLUSIVE ENTERAL NUTRITION BE PREDICTED AT DIAGNOSIS? P051
CLINICAL AND LABORATORY VARIABLES THAT PREDICT CLINICAL AND ENDOSCOPIC REMISSION IN CHILDREN WITH CROHN’S DISEASE TREATED WITH INFLIXIMAB P052
CLINICAL COURSE AFTER INDUCTION THERAPY WITH INFLIXIMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE P053
THE RESULTS OF 1 YEAR INFLIXIMAB TREATMENT IN CHILDREN WITH CROHN’S DISEASE – THE PIT-STOP STUDY P054
INFLIXIMAB IN PEDIATRIC INFLAMATORY BOWEL DISEASE: MAINTAINING OR CHANGING THE THERAPY P055
OUT OF WINDOW INFLIXIMAB INFUSIONS DO NOT DRIVE LOSS OF RESPONSE OR LOW TROUGH DRUG LEVELS P056
INDIVIDUALISED INFLIXIMAB TREATMENT GUIDED BY PATIENT-MANAGED EHEALTH IN CHILDREN AND ADOLESCENTS WITH IBD P057
PROACTIVE APPROACH OF THERAPEUTIC DRUG MONITORING (TDM) IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE (PIBD) ON MAINTENANCE BIOLOGIC TREATMENT IMPROVES CLINICAL REMISSION P058
ASSOCIATION BETWEEN INFLIXIMAB TROUGH LEVELS, ANTIBODIES TO INFLIXIMAB AND CLINICAL REMISSION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASES P059
POST-INDUCTION SERUM INFLIXIMAB TROUGH LEVELS ARE CAPABLE OF PREDICTING ‘EN BLOC’ REMISSION IN PEDIATRIC CROHN’S DISEASE PATIENTS UNDER COMBINED IMMUNOSUPPRESSION P060
CLINICAL UTILITY OF THERAPEUTIC DRUG MONITORING IN PREDICTING MUCOSAL HEALING IN PEDIATRIC CROHN’S DISEASE PATIENTS UNDER MAINTENANCE INFLIXIMAB TREATMENT P061
COMBINATION THERAPY WITH METHOTREXATE DOES NOT APPEAR TO CHANGE INFLIXIMAB TROUGH LEVELS NOR ANTI-INFLIXIMAB ANTIBODIES IN CHILDREN P063

 

 

EFFECTIVENESS OF BIOSIMILAR INFLIXIMAB (CT-P13) IN INDUCTION OF REMISSION AND MUCOSAL HEALING IN PAEDIATRIC CROHN DISEASE: SINGLE CENTRE EXPERIENCE. P063
EVALUATION OF ADALIMUMAB EFFECTIVENESS IN ANTI-TUMOR NECROSIS FACTOR-NAÏVE PEDIATRIC PATIENTS WITH CROHN’S DISEASE IN CLINICAL PRACTICE P064
EFFICACY OF FIRST LINE TOP-DOWN ADALIMUMAB THERAPY P065
POTENTIAL UTILITY OF THERAPEUTIC DRUG MONITORING OF ADALIMUMAB IN PREDICTING SHORT-TERM ENDOSCOPIC AND HISTOLOGIC REMISSION IN PEDIATRIC CROHN’S DISEASE PATIENTS P066
EVOLUTION OF THE ANTI-TNF TROUGH LEVELS AFTER WITHDRAWAL OF THIOPURINES IN PEDIATRIC IBD PATIENTS ON COMBINATION THERAPY P067
THE LOCAL SURVEY: USE OF BIOLOGICAL THERAPIES IN PEDIATRIC IBD PATIENTS IN SPAIN P068
PRESENCE AND SEVERITY OF ULCERATIONS IN CROHN DISEASE DOES NOT CONTRIBUTE TO RESPONSE FOR INDUCTION THERAPY WITH INFLIXIMAB IN CHILDREN P069
PRESENCE AND SEVERITY OF ULCERATIONS IN CROHN DISEASE CONTRIBUTE TO THE COURSE OF MAINTENANCE THERAPY WITH INFLIXIMAB IN CHILDREN. P070
THERAPEUTIC DRUG MONITORING DURING INFLIXIMAB INDUCTION IN PAEDIATRIC IBD: A MULTICENTRE PROSPECTIVE COHORT STUDY P071
ANTI-TNFΑ TREATMENT FOLLOWING SURGICAL RESECTION FOR CROHN’S DISEASE IS EFFECTIVE DESPITE PREVIOUS PHARMACODYNAMIC FAILURE P072
INFLIXIMAB INDUCED PSORIASIS IN A COHORT OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE : A 12 YEARS FOLLOW-UP STUDY. P073
SKIN MANIFESTATIONS IN MONOCLONAL THERAPY OF PAEDIATRIC INFLAMMATORY BOWEL DISEASE (PIBD). P074
SHARED DECISION MAKING IN THE CHOICE OF ANTI-TNF ALPHA IN PAEDIATRIC CORHN’S DISEASE P075
VEDOLIZUMAB FOR STEROID REFRACTORY ULCERATIVE COLITIS UNRESPONSIVE TO ANTI-TNF; A SINGLE CENTRE EXPERIENCE P076
THERAPEUTIC APPROACHES FOR PERIANAL FISTULA IN PAEDIATRIC AND ADOLESCENT ONSET CROHN`S
DISEASE-A MULTICENTRE COHORT STUDY
P077
DIFFERENCES IN THERAPY APPROACHES AND OUTCOMES IN PAEDIATRIC AND ADULT ONSET PERIANAL FISTULISING CROHN’S: COMPARING 2 ECCO COLLABORATIVE FISTULA  COHORTS P078
ABDOMINAL SURGERY IN PATIENTS WITH CROHN´S DISEASE IN 2011-2016 – RETROSPECTIVE SINGLE CENTRE DATA P079
POSTOPERATIVE MID-TERM PROGNOSIS IN PATIENTS WITH PEDIATRIC ONSET CROHN’S DISEASE P080
CLINICAL CHARACTERISTICS AND SURGICAL OUTCOME OF PEDIATRIC, ADULT, ELDERLY PATIENTS WITH ULCERATIVE COLITIS WHO UNDERWENT SURGERY IN A SINGLE CENTER P081
FECAL MICROBIOTA TRANSPLANTATION  FOR CYTOMEGALOUSVIRUS INFECTION IN PEDIATRIC PATIENTS WITH ACUTE SEVERE COLITIS P082
USE OF FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN CHILDREN AFFECTED BY INFLAMMATORY BOWEL DISEASE P083
MONITORING MUCOSAL HEALING WITH FAECAL CALPROTECTIN IN CHILDREN WITH ULCERATIVE COLITIS. P084
NON-INVASIVE METHODS OF ASSESING MUCOSAL STATE IN CHILDREN WITH CROHN’S DISEASE. P085
EXPENSIVE MEANS BETTER? COMPARISON OF TWO FAECAL CALPROTECTIN ASSAYS IN MONITORING CHILDREN WITH INFLAMMATORY BOWEL DISEASE. P086
HOME OR HOSPITAL-BASED ANALYSIS OF STOOL CALPROTECTIN: ASSESSING TWO METHODS FOR MONITORING INFLAMMATORY BOWEL DISEASE P087
ROLE OF FECAL CALPROTECTIN AS PREDICTOR OF ENDOSCOPIC ACTIVITY IN PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS P088
ROLE OF FECAL CALPROTECTIN AS PREDICTOR OF ENDOSCOPIC ACTIVITY IN PEDIATRIC PATIENTS WITH CROHN’S DISEASE P089
QUALITY OF LIFE IN PAEDIATRIC CROHN’S DISEASE: DATA FROM THE IMAGEKIDS STUDY P090
QUALITY OF LIFE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENT: CORRELATION WITH CLINICAL CHARACTERISTICS. P092
QUALITY OF LIFE IN PEDIATRIC IBD. WHAT IS THE PARENTAL AND PEERS PERSPECTIVE? P092
PREVALENCE OF ANXIETY AND DEPRESSION IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IN A DUTCH COHORT P093
CURRENT ASSESSMENT OF A TRANSITION CARE PROGRAM IN INFLAMMATORY BOWEL DISEASE IN TERTIARY HOSPITAL: PERCEPTIONS FROM SURVEYS OF PEDIATRIC PATIENTS P094
ANEMIA, DISEASE ACTIVITY AND  HEALTH RELATED QUALITY OF LIFE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE P095
ORAL IMPLEMENTATION OF EEN IS GOOD TOLERATED METHOD TO INDUCE REMISION AND NORMALIZE NUTRITIONAL STATUS IN CHILDREN WITH ACTIVE CD. P096
PSYCHOLOGICAL AND NUTRITIONAL GROUP INTERVENTION PROGRAM IN INFLAMMATORY BOWEL DISEASE ADOLESCENT PATIENTS P097
SUBJECTIVE VERSUS OBJECTIVE ASSESSMENT OF NUTRITIONAL STATUS IN PEDIATRIC IBD (PIBD) IN A TERTIARY CENTER. P098
INDEPENDENT DIAGNOSIS OF ANEMIA IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE RESULTS IN INCREASED INITIATION OF ANEMIA TREATMENT P099
HYPOZINCEMIA IN CHILDREN WITH IBD – A SINGLE CENTER RETROSPECTIVE STUDY – P100
GIANT POSTINFLAMMATORY PSEUDOPOLYPOSIS AS A RESULT OF ”HEALING“ OF ULCERATIVE COLITIS IN A 13-YEAR-OLD GIRL P101
PULMONARY NECROBIOTIC NODULES: A RARE MANIFESTATION OF CROHN’S DISEASE IN PEDIATRIC PATIENTS P102
FUNCTIONAL ANALYSIS IMPLICATING SAMD9 MUTATIONS IN INTESTINAL INFLAMMATION IN PATIENTS WITH MIRAGE SYNDROME. P103
A CASE OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE INITIALLY PRESENTING AS EOSINOPHILIC COLITIS P104
PAEDIATRIC CROHN’S DISEASE AND METASTATIC COLORECTAL ADENOCARCINOMA P105
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS IN CHILDREN AFFECTED BY INFLAMMATORY BOWEL DISEASE P106
EARLY ONSET INFLAMMATORY COLITIS IN A PATIENT WITH CONGENITAL CHLORIDE DIARRHOEA (CCD) P107
CUTANEOUS MANIFESTATIONS OF PAEDIATRIC CROHN’S DISEASE P108
VENOUS THROMBOSIS AS A FORM OF PRESENTATION IN IBD – CASE REPORT P109
EXPLORING THE ROLE OF PTPRT IN THE PATHOGENESIS OF VEO-IBD P110
INFLAMMATORY BOWEL DISEASE AND TAKAYASU’S ARTERITIS AN ASSOCIATION? P111
AN UNSOLVED CASE OF A VERY EARLY ONSET IBD P112